Valuation (48%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 42.86 | N/A |
| PEG Ratio (TTM) | -1.63 | N/A |
| P/S Ratio (TTM) | 1.98 | N/A |
| P/B Ratio (TTM) | 0.84 | N/A |
| P/FCF Ratio (TTM) | -389.00 | N/A |
| Price to 5YR AVG Earnings Ratio | 16.31 | N/A |
| Price to 5YR AVG FCF Ratio | 10.48 | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.20% | N/A |
| ROE (TTM) | 1.97% | N/A |
| Net Profit Margin (TTM) | 4.30% | N/A |
| ROIC 5YR AVG | 6.87% | N/A |
Growth (72%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -6.49% | 84.58% | 35.34% |
| Revenue | 7.53% | 22.07% | 7.30% |
| Net Income | -7.04% | 78.72% | 29.87% |
| Cash Flow | -13.17% | 266.18% | 138.64% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.34 | N/A |
| Quick Ratio (TTM) | 0.34 | N/A |
| D/E Ratio (TTM) | 0.92 | N/A |
| Interest Coverage (TTM) | 0.74 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | 5.29 | N/A |
| Shares Outstanding Growth 5YR AVG | -5.24% | N/A |